Amolyt Pharma Alternatives & Competitors
12 companies similar to Amolyt Pharma — Advancing peptides for the treatment of rare endocrine and related diseases
Companies similar to Amolyt Pharma
Gan & Lee Pharmaceuticals
Science & Excellence
China
Medesis Pharma
Une technologie pour délivrer des médicaments dans toutes les cellules à partir d'une admi...
France
NeuroScientific Biopharmaceuticals Ltd
Novel drug therapies for neurodegenerative conditions
Australia
San Diego, United States
Rival Readout
Competing with Amolyt Pharma? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Soleno Therapeutics, Inc.
Inspired by patients and families around the world, we are advancing much needed therapies...
Redwood City, United Stat...
Scarlet Therapeutics Ltd
We believe the future of medicine is in our blood.
Bristol, United Kingdom
Acceleron Pharma
Accelerating drug discovery to transform patients' lives
Cambridge, United States
KAMADA
Specialty Plasma-Derived Therapeutics
Rehovot, Israel
Dualyx
Discovery and development of highly innovative biologicals for the treatment of autoimmune...
Belgium
VG Life Sciences
Developing lifesaving therapies for drug-resistant cancers and autoimmune diseases through...
VISEN Pharmaceuticals
Achieve better treatment processes and outcomes by combining global expertise and strength...
China
ANA Therapeutics
We’re investigating niclosamide as a treatment for COVID-19.
San Mateo, United States
About Amolyt Pharma
Amolyt Pharma is a biotechnology company founded in 2015, headquartered in France, and dedicated to developing innovative treatments for rare endocrine and related diseases. The company's slogan "Advancing peptides for the treatment of rare endocrine and related diseases" underscores its focus on using peptides to addr...
Biopharmaceutical research and development, clinical trials, precision medicine, healthcare delivery
Patients, healthcare providers, research institutions, pharmaceutical industry
Therapeutic Peptides, Rare Disease Treatment, Endocrinology, Metabolic Disorder Treatment, Hypoparathyroidism, Acromegaly, Peptide Drug Development, Endocrine Disease, Biopharmaceuticals, Clinical Research, Global Network, Investor Syndicate
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Amolyt Pharma: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Amolyt Pharma on 11 Jun 2025. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
